Researchers at The University of Texas MD Anderson Cancer Center have discovered that immunosuppressed patients with non-melanoma skin cancer are not missing the key cancer-fighting macrophages found in immunocompetent patients. Instead, those cells have lost the ability to communicate effectively. The researchers say this new understanding may help researchers develop new treatment approaches for these aggressive skin cancers. The study was published in Cell. Moran Amit, MD,

In photodynamic therapy, a light-sensitive drug accumulates in cancer cells and is then activated by light, producing cell-killing molecules. Microneedles can help deliver the drug and distribute light more effectively within non-melanoma skin cancer. Image by M. Requena et al. A biodegradable microneedle patch designed to deliver treatment through the skin may also guide and scatter light, potentially allowing photodynamic therapy (PDT) to treat nonmelanoma skin cancers more

One in five Brits will develop an NMSC in their lifetime A new study has attempted to stratify the impact of non-melanoma skin cancer...

The rates of keratinocyte carcinomas (KCs) in Ontario, Canada increased 30% between 2003 and 2017. These findings come from a paper...